Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07009236
Recruiting
A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma
Not applicable · United Kingdom, Honduras · 5 sites
Registry update: 22 Oct 2026
NCT07203742
Recruiting
The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment
Not applicable · 1 site
Registry update: 17 Feb 2026
NCT06912087
Recruiting
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
Phase 1 · United States · 1 site
Registry update: 2 Dec 2025
NCT07011576
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Phase 2 · United States · 14 sites
Registry update: 12 Jun 2026
NCT07035886
Recruiting
A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea
Not applicable · South Korea · 1 site
Registry update: 27 Feb 2026
NCT07069660
Recruiting
Compass 3: A Novel Transition Program to Reduce Disability After Stroke
Not applicable · United States · 2 sites
Registry update: 13 Feb 2026
NCT06979336
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Phase 2 · Australia, Brazil, Canada, China, Czechia, Germany, France, United Kingdom, India, Italy, Japan, South Korea, Mexico, Poland, United States · 118 sites
Registry update: 27 Oct 2026
NCT07616375
Recruiting
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Phase 3 · China · 1 site
Registry update: 1 Jun 2026
NCT06939855
Recruiting
QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 19 Nov 2025
NCT07449039
Recruiting
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
Not applicable · United States · 1 site
Registry update: 4 Mar 2026
NCT07187635
Recruiting
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
Not applicable · China · 7 sites
Registry update: 3 Nov 2026
NCT07288788
Recruiting
Assessment of Kidney Function in Patients With Epilepsy
Not applicable · Egypt · 2 sites
Registry update: 17 Dec 2025
NCT07289997
Recruiting
Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)
Phase 2 · China · 1 site
Registry update: 17 Dec 2025
NCT07028853
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Phase 3 · Argentina, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, China, Czechia, Germany, Spain, Finland, France, United Kingdom, Greece, Israel, Italy, Japan, South Korea, Netherlands, New Zealand, Poland, Slovakia, Taiwan, United States · 333 sites
Registry update: 14 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT07192341
Recruiting
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
Not applicable · Egypt · 1 site
Registry update: 30 Sept 2025
NCT07217223
Recruiting
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
Not applicable · United States · 1 site
Registry update: 15 Sept 2026
NCT07083154
Recruiting
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
Phase 3 · China · 8 sites
Registry update: 2 Sept 2026
NCT07290010
Recruiting
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
Phase 2 · China · 1 site
Registry update: 17 Dec 2025
NCT07193628
Recruiting
B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma
Phase 1 · China · 1 site
Registry update: 18 Nov 2025
NCT07071103
Recruiting
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Phase 2 · China · 1 site
Registry update: 20 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.